Focal nodular hyperplasia
✍ Scribed by Paulette Bioulac-Sage; Hervé Trillaud; Christophe Laurent; Charles Balabaud; Claude Degott
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 145 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
✦ Synopsis
We read with interest the paper by Fabre et al.1 We agree with their major remark that the absence of radiologic criteria for focal nodular hyperplasia (FNH) does not preclude a positive diagnosis of liver needle biopsy as seen in 11 of 24 cases of group 111 (showing 2 or fewer
📜 SIMILAR VOLUMES
Focal nodular hyperplasia (FNH) has been well characterized in native livers, but to our knowledge, no cases of FNH have been described in liver allografts. We review the clinicopathological features of 6 FNHs identified in 4 patients after orthotopic liver transplantation. There were 3 male patient
## Abstract ## Purpose: To illustrate the unusual enhancement pattern of the focal nodular hyperplasia central scar using Gadoxetate Disodium. ## Materials and Methods: Over a 10‐month period, six patients, with a total of seven focal nodular hyperplasia lesions with typical central scar, had MR
Focal nodular hyperplasia (FNH) and adenoma are rare benign hepatic tumors, and the standards for diagnosis and treatment still remain controversial. Usually adenoma is an indication for resection, due to its tendency to bleed and to degenerate; FNH, on the contrary, may be treated conservatively. P
Sixteen cases of focal nodular hyperplasia (FNH) of the liver were followed by ultrasound (US) for a mean of 33 months (range 6-81). In 69% of the cases, the diagnosis was incidental. On US the lesions were single in 75% of the cases, localized in the right lobe in 75%, and subcapsular in 50%. No sp